logo

For the Inventor, By the Inventor

Hyogo, Japan

Masakuni Kori

This inventor holds 9 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1996-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masakuni Kori. Retrieved from https://idiyas.com/inventor/masakuni-kori-ew7puvli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 56(Granted Patents)


Location History:

  • Miki, JP (1996 - 1997)
  • Hyogo, JP (1997 - 1999)

Company Filing History:

goldMedal9 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1996-1999

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5955491 - Method for treating osteoporosis (1999-09-21),
2. 5885979 - N-containing condensed heterocyclic compounds, their production, and (1999-03-23),
3. 5770438 - Process for enantioselective hydrolysis of (1998-06-23),
4. 5726306 - 4,1-benzoxazepin derivatives and their use (1998-03-10),
5. 5716980 - Alcohol or aldehyde derivatives and their use (1998-02-10),
6. 5698691 - Condensed cyclic compounds and their use (1997-12-16),
7. 5677298 - Benzoxazepine-2-one compounds and their use (1997-10-14),
8. 5639781 - Alcohol or aldehyde derivatives and their use (1997-06-17),
9. 5498728 - Derivatives of L-tryptophanal and their use as medicinals (1996-03-12),

Title: Masakuni Kori: Innovator in Pharmaceutical Patents

Introduction

Masakuni Kori is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various health issues. With a total of 9 patents to his name, Kori's work has had a substantial impact on medical treatments.

Latest Patents

One of Kori's latest patents is a method for treating osteoporosis. This invention provides a cathepsin L inhibitor containing a specific compound formula. The compound includes various substituents that enhance its effectiveness. Additionally, Kori has developed N-containing condensed heterocyclic compounds that are useful for inhibiting squalene synthetase and fungal growth. These compounds are also beneficial for treating or preventing hyperlipidemia. The methods for producing these compounds are also disclosed in his patents.

Career Highlights

Kori is currently associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to focus on innovative solutions for complex health challenges. His patents reflect a deep understanding of medicinal chemistry and a commitment to improving patient outcomes.

Collaborations

Throughout his career, Kori has collaborated with esteemed colleagues, including Takashi Sohda and Yukio Fujisawa. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Masakuni Kori's contributions to the pharmaceutical industry through his patents demonstrate his dedication to advancing medical science. His innovative approaches to treating health conditions continue to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…